London Regional Cancer Program, London Health Sciences Centre

London

0 studies enrolling now · 2 studies all time

What they study most

Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck

Studies at this site

• A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) — Running, not enrolling
• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early